Quick Answer
GoHealth, Inc. reported Cash and Equivalents of $32.90 million for fiscal year 2025.
GoHealth, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $32.90M | -19.6% |
| 2024 | $40.92M | -54.9% |
| 2023 | $90.81M | +451.6% |
| 2022 | $16.46M | -80.5% |
| 2021 | $84.36M | -41.5% |
| 2020 | $144.23M | +1074.9% |
| 2019 | $12.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.08M | -9.7% | -9.9% |
| June 30, 2025 | $35.59M | +152.0% | +60.7% |
| March 31, 2025 | $22.15M | -77.4% | -45.9% |
| December 31, 2024 | $40.92M | -54.9% | +15.2% |
| September 30, 2024 | $35.53M | +34.6% | +151.5% |
| June 30, 2024 | $14.12M | -44.3% | -85.6% |
| March 31, 2024 | $97.82M | +202.6% | +7.7% |
| December 31, 2023 | $90.81M | +451.6% | +244.1% |
- GoHealth, Inc. showed a decrease of -19.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, GoHealth, Inc.’s cash and equivalents has grown by 168.0% (from $12.28 million to $32.90 million).
- The most recent figure is from GoHealth, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: